Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hematologic Neoplasms × tafasitamab × 90 days × Clear all

Sponsor

Conditions

Recurrence 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

fludarabine 15 Cyclophosphamide 15 Mycophenolic Acid 9 venetoclax 8 Whole-Body Irradiation 8 fludarabine phosphate 7 Specimen Handling 7 Standard of Care 6 Sirolimus 6 Melphalan 6 Thiotepa 5 Tacrolimus 5 Mesna 5 Busulfan 5 trametinib 4 Practice Guidelines as Topic 4 Filgrastim 4 Azacitidine 4 Surveys and Questionnaires 3 Granulocyte Colony-Stimulating Factor 3 Biopsy 3 thymoglobulin 2 talquetamab 2 pembrolizumab 2 dabrafenib 2 Stem Cell Transplantation 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Palliative Care 2 Methylprednisolone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡